Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 28 (LINC00028) is a human long non-coding RNA located on chromosome 20, designated by multiple aliases including C20orf93, NCRNA00028, and dJ1093G12.6[3][5][7][8]. LINC00028 does not encode a protein; rather, it regulates gene expression at the RNA level, primarily functioning as a molecular sponge for microRNAs such as miR-204-5p[1]. Its upregulation has been associated with enhanced proliferation, migration, epithelial-mesenchymal transition, fibrosis, and autophagy in human tenon capsule fibroblasts, particularly after stimulation with TGFβ1 in the context of glaucoma filtration surgery scar formation[1]. Because of this regulation, LINC00028 is being explored as a potential biomarker for fibrotic complications in glaucoma but is not considered a classical therapeutic target such as a receptor, enzyme, or transporter[1][3][9]. No current drugs, small molecule inhibitors, or established mechanisms of action are known to target LINC00028 directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 28 (LINC00028).